Abstract
Bonn Risk Index (BRI) is being used for the assessment of urinary calcium oxalate (CaOx) crystallization. There are no published data regarding BRI during growth. The objective of this study was to establish age- and sex-dependent BRI values in healthy children and adolescents. A total of 1,050 Caucasian subjects aged 3–18 years (525 males, 525 females) without a history of kidney stone disease were enrolled in the cross-sectional study. The study group was divided into 15 ranges according to age, each comprising 70 subjects. Urinary ionized calcium [Ca2+] was measured using a selective electrode while the onset of spontaneous crystallization was determined using a photometer and titrating with 40 mmol/L ammonium oxalate (Ox2−). The calculation of BRI value was based on the ratio of [Ca2+] to the required amount of ammonium oxalate added to 200 ml of urine to induce crystallization. The median BRI was 0.26 1/L and the values of the 5th and 95th percentiles were 0.06 1/L and 1.93 1/L, respectively. BRI correlated positively with body-area-related BRI (1/L × 1.73 m2) (R = 0.18; P < 0.05), whereas a negative correlation was found between BRI and body weight (1/L × kg) (R = −0.85; P < 0.05). Neither sex nor age differences were detected in BRI across studied children and adolescents. The values of Bonn Risk Index were constant during growth and there was a limited influence of age and sex on BRI in children over 3 years of age. The BRI may be valuable in the evaluation of pediatric patients at risk for kidney stones, particularly if the BRI from stone formers is demonstrated to be higher than in normal children.
Similar content being viewed by others
Abbreviations
- AP:
-
activity product
- BMI:
-
Body Mass Index
- BRI:
-
Bonn Risk Index
- [Ca2+]:
-
ionized calcium concentration
- CaOx:
-
calcium oxalate
- (Ox2−):
-
amount of ammonium oxalate added to 200 ml of urine to induce crystallization
References
Kraus SJ, Lebowitz RL, Royal SA (1999) Renal calculi in children: imaging features that lead to diagnoses: a pictorial essay. Pediatr Radiol 29:624–630
Cameron MA, Sakhaee K, Moe OW (2005) Nephrolithiasis in children. Pediatr Nephrol 20:1587–1592
Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31:927–949
Sayer JA, Carr G, Simmons NL (2004) Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci 106:549–561
Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A (2003) Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 8:437–443
Kavanagh JP, Laube N (2006) Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls? J Urol 175:766–770
Tiselius HG (1997) Risk formulas in calcium oxalate urolithiasis. World J Urol 15:176–185
Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 134:1242–1244
Laube N, Schneider A, Hesse A (2000) A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res 28:274–280
Lewandowski S, Rodgers AL, Laube N, von Unruh G, Zimmermann D, Hesse A (2005) Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol 6:1–4
Kunachowicz H, Nadolna I, Przygoda B, Iwanow K (1998) Food composition tables. National Food and Nutrition Institute, Warsaw
Laube N, Hergarten S, Hesse A (2002) Comparison of a laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med 40:595–599
Palczewska I, Szilágyi-Pągowska I (2002) Ocena rozwoju somatycznego dzieci i młodzieży. Med Prakt Ped 3200:140–148
Chandhoke PS (2002) When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol 168:937–940
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823
Kok DJ (2002) Clinical implications of physicochemistry of stone formation. Endocrinol Metab Clin North Am 31:855–867
Kavanagh JP (2006) In vitro calcium oxalate crystallisation methods. Urol Res 14:1–7
Hoppe B, Jahnen A, Bach D, Hesse A (1997) Urinary calcium oxalate saturation in healthy infants and children. J Urol 158:557–559
Lande MB, Varade W, Erkan E, Niederbracht Y, Schwartz GJ (2005) Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol 20:491–494
Laube N, Hergarten S (2005) Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions? J Urol 175:2175–2177
Teller WM, Burke EC, Rosevaer JW, McKenzie BF (1962) Urinary excretion of acid mucopolysaccharides in normal children and patients with gargoylism. J Lab Clin Med 59:95–101
Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL (2002) Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol 167:2372–2376
Ricchiuti V, Hartke DM, Yang LZ, Goldman HB, Elder JS, Resnick MI, Marengo SR (2002) Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int 99:513–517
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Porowski, T., Zoch-Zwierz, W., Wasilewska, A. et al. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol 22, 514–520 (2007). https://doi.org/10.1007/s00467-006-0383-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0383-0